Clinical Trial: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403188) titled 'A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101' on Dec. 18, 2025.

Brief Summary: The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in participants who have been administered KYV-101 (gene-modified product; autologous CAR T cell product).

This LTFU protocol will be open to any participant who received at least one infusion of KYV-101 in a previous Kyverna sponsored clinical trial or Investigator Initiated Trial (IIT).

Study Start Date: Nov. 24, 2025

Study Type...